Keywords
Last Name
Institution

William L Baker Jr. PharmD, BCPS

TitleAssistant Clinical Professor
InstitutionUniversity of Connecticut
DepartmentPharmacy Practice
AddressUNIT 3092
Pharmacy/Bio, UNIT 3092
69 N Eagleville Road
Phone860-679-3889
vCardDownload vCard
    Other Positions
    TitleAssistant Professor
    InstitutionUConn Health Center
    DepartmentMedicine


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Baker WL, Jennings DL. Pre-Cardiac Transplant Amiodarone Use Increases Postoperative Mortality: A Meta-analysis. Ann Pharmacother. 2016 Jun; 50(6):514-5. PMID: 27083918.
      View in: PubMed
    2. Baker WL, Johnson SG. Pharmacogenetics and oral antithrombotic drugs. Curr Opin Pharmacol. 2016 Apr; 27:38-42. PMID: 26878737.
      View in: PubMed
    3. Linder KE, Baker WL, Rochon C, May ST, Sheiner PA, Martin ST. Evaluation of Posttransplantation Diabetes Mellitus After Liver Transplantation: Assessment of Insulin Administration as a Risk Factor. Ann Pharmacother. 2016 May; 50(5):369-75. PMID: 26847860.
      View in: PubMed
    4. White WB, Baker WL. Cardiovascular Effects of Incretin-Based Therapies. Annu Rev Med. 2016 Jan 14; 67:245-60. PMID: 26768240.
      View in: PubMed
    5. Baker WL, Kluger J, Coleman CI, White CM. Impact of Magnesium L-Lactate on Occurrence of Ventricular Arrhythmias in Patients with Implantable Cardioverter Defibrillators: A Randomized, Placebo-Controlled Trial. Open Cardiovasc Med J. 2015; 9:83-8. PMID: 27006710.
      View in: PubMed
    6. Baker WL, Saulsberry WJ, Elliott K, Parker MW. Cardiac MRI-confirmed mesalamine-induced myocarditis. BMJ Case Rep. 2015; 2015. PMID: 26341161.
      View in: PubMed
    7. Baker WL, Radojevic J, Gluck JA. Systematic Review of Phosphodiesterase-5 Inhibitor Use in Right Ventricular Failure Following Left Ventricular Assist Device Implantation. Artif Organs. 2016 Feb; 40(2):123-8. PMID: 26043796.
      View in: PubMed
    8. Baker WL, Coleman CI. Medication adherence and non-vitamin K antagonist oral anticoagulants: what do we really know? Europace. 2015 Aug; 17(8):1316-7. PMID: 26045505.
      View in: PubMed
    9. Chamberlin KW, Baker WL. Benefit-risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients. Clin Interv Aging. 2015; 10:733-40. PMID: 25931816; PMCID: PMC4404990.
    10. Azim S, Baker WL, White WB. Evaluating cardiovascular safety of novel therapeutic agents for the treatment of type 2 diabetes mellitus. Curr Cardiol Rep. 2014 Nov; 16(11):541. PMID: 25303895.
      View in: PubMed
    11. Majumder S, Bockorny B, Baker WL, Dasanu CA. Association between HBsAg positivity and pancreatic cancer: a meta-analysis. J Gastrointest Cancer. 2014 Sep; 45(3):347-52. PMID: 24788082.
      View in: PubMed
    12. Limone BL, Baker WL, Mearns ES, White CM, Kluger J, Coleman CI. Common flaws exist in published cost-effectiveness models of pharmacologic stroke prevention in atrial fibrillation. J Clin Epidemiol. 2014 Oct; 67(10):1093-102. PMID: 25018102.
      View in: PubMed
    13. Baker WL, Chamberlin KW. New oral anticoagulants vs. warfarin treatment: no need for pharmacogenomics? Clin Pharmacol Ther. 2014 Jul; 96(1):17-9. PMID: 24942397.
      View in: PubMed
    14. Baker WL, Nigro SC, White WB. Efficacy of azilsartan medoxomil with chlorthalidone in hypertension. Expert Rev Cardiovasc Ther. 2014 Jul; 12(7):791-8. PMID: 24881461.
      View in: PubMed
    15. Gale AM, Kaur R, Baker WL. Hemodynamic and electrocardiographic effects of açaí berry in healthy volunteers: a randomized controlled trial. Int J Cardiol. 2014 Jun 15; 174(2):421-3. PMID: 24767759.
      View in: PubMed
    16. Baker WL, Smyth LR, Riche DM, Bourret EM, Chamberlin KW, White WB. Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: a systematic review and meta-analysis. J Am Soc Hypertens. 2014 Apr; 8(4):262-75.e9. PMID: 24602971.
      View in: PubMed
    17. Baker WL. The changing face of anticoagulation management: an improving countenance. Pharmacotherapy. 2013 Nov; 33(11):1133-5. PMID: 24590595.
      View in: PubMed
    18. Sobieraj DM, Cappelleri JC, Baker WL, Phung OJ, White CM, Coleman CI. Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review. BMJ Open. 2013; 3(7). PMID: 23878173; PMCID: PMC3717466.
    19. Nigro SC, Luon D, Baker WL. Lorcaserin: a novel serotonin 2C agonist for the treatment of obesity. Curr Med Res Opin. 2013 Jul; 29(7):839-48. PMID: 23574263.
      View in: PubMed
    20. Limone BL, Baker WL, Kluger J, Coleman CI. Novel anticoagulants for stroke prevention in atrial fibrillation: a systematic review of cost-effectiveness models. PLoS One. 2013; 8(4):e62183. PMID: 23626785; PMCID: PMC3633898.
    21. Baker WL, Coleman CI, White CM, Kluger J. Use of preoperative CHA2 DS2 -VASc score to predict the risk of atrial fibrillation after cardiothoracic surgery: a nested case-control study from the Atrial Fibrillation Suppression Trials (AFIST) I, II, and III. Pharmacotherapy. 2013 May; 33(5):489-95. PMID: 23649811.
      View in: PubMed
    22. Baker WL, Marrs JC, Davis LE, Nutescu EA, Rowe AS, Ryan M, Splinter MY, Vardeny O, Fagan SC. Key articles and guidelines in the acute management and secondary prevention of ischemic stroke. Pharmacotherapy. 2013 Jun; 33(6):e115-42. PMID: 23401103.
      View in: PubMed
    23. Baker WL, Marrs JC, Davis LE, Nutescu EA, Rowe AS, Ryan M, Splinter MY, Vardeny O, Fagan SC. Key articles and guidelines in the primary prevention of ischemic stroke. Pharmacotherapy. 2013 Jun; 33(6):e101-14. PMID: 23401140.
      View in: PubMed
    24. Sobieraj DM, White WB, Baker WL. Cardiovascular effects of pharmacologic therapies for smoking cessation. J Am Soc Hypertens. 2013 Jan-Feb; 7(1):61-7. PMID: 23266101; PMCID: PMC3549329.
    25. Baker WL, Phung OJ. Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2012 Sep 1; 5(5):711-9. PMID: 22912382.
      View in: PubMed
    26. Rai M, Baker WL, Parker MW, Heller GV. Meta-analysis of optimal risk stratification in patients >65 years of age. Am J Cardiol. 2012 Oct 15; 110(8):1092-9. PMID: 22795509.
      View in: PubMed
    27. Baker EL, Coleman CI, Reinhart KM, Phung OJ, Kugelman L, Chen W, White CM, Mamolo CM, Cappelleri JC, Baker WL. Effect of Biologic Agents on Non-PASI Outcomes in Moderate-to-Severe Plaque Psoriasis: Systematic Review and Meta-Analyses. Dermatol Ther (Heidelb). 2012 Dec; 2(1):9. PMID: 23205332; PMCID: PMC3510417.
    28. Baker WL, White WB. Safety of mineralocorticoid receptor antagonists in patients receiving hemodialysis. Ann Pharmacother. 2012 Jun; 46(6):889-94. PMID: 22669801.
      View in: PubMed
    29. Talati R, Scholle JM, Phung OP, Baker EL, Baker WL, Ashaye A, Kluger J, Coleman CI, White CM. Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review. Pharmacotherapy. 2012 Apr; 32(4):314-22. PMID: 22461121.
      View in: PubMed
    30. Ching GG, Li D, Baker WL, Hohl PK, Mather JF, McKay RG, Lundbye JB. Major adverse cardiac events among postpercutaneous coronary intervention patients on clopidogrel and proton pump inhibitors. Conn Med. 2012 Apr; 76(4):205-11. PMID: 22611719.
      View in: PubMed
    31. Baker WL, White WB. Azilsartan medoxomil: a new angiotensin II receptor antagonist for treatment of hypertension. Ann Pharmacother. 2011 Dec; 45(12):1506-15. PMID: 22116996.
      View in: PubMed
    32. Rathier MO, Baker WL. A review of recent clinical trials and guidelines on the prevention and management of delirium in hospitalized older patients. Hosp Pract (1995). 2011 Oct; 39(4):96-106. PMID: 22056829.
      View in: PubMed
    33. Campbell P, Baker WL, Bendel SD, White WB. Intravenous hydralazine for blood pressure management in the hospitalized patient: its use is often unjustified. J Am Soc Hypertens. 2011 Nov-Dec; 5(6):473-7. PMID: 21890447; PMCID: PMC3218202.
    34. Colby JA, Chen WT, Baker WL, Coleman CI, Reinhart K, Kluger J, White CM. Effect of ascorbic acid on inflammatory markers after cardiothoracic surgery. Am J Health Syst Pharm. 2011 Sep 1; 68(17):1632-9. PMID: 21856809.
      View in: PubMed
    35. Chen WT, White CM, Phung OJ, Kluger J, Ashaye A, Sobieraj D, Makanji S, Tongbram V, Baker WL, Coleman CI. Are the risk factors listed in warfarin prescribing information associated with anticoagulation-related bleeding? A systematic literature review. Int J Clin Pract. 2011 Jul; 65(7):749-63. PMID: 21676118.
      View in: PubMed
    36. Baker WL, Karan S, Kenny AM. Effect of dehydroepiandrosterone on muscle strength and physical function in older adults: a systematic review. J Am Geriatr Soc. 2011 Jun; 59(6):997-1002. PMID: 21649617.
      View in: PubMed
    37. Phung OJ, Baker WL, Baker EL, Coleman CI. Intent to update systematic reviews: results of an internet survey. J Investig Med. 2011 Jun; 59(5):811-5. PMID: 21343828.
      View in: PubMed
    38. Chen WT, White CM, Phung OJ, Kluger J, Ashaye AO, Sobieraj DM, Makanji S, Tongbram V, Baker WL, Coleman CI. Association between CHADS2risk factors and anticoagulation-related bleeding: a systematic literature review. Mayo Clin Proc. 2011 Jun; 86(6):509-21. PMID: 21628615; PMCID: PMC3104910.
    39. Bendel SD, Bona R, Baker WL. Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation. Adv Ther. 2011 Jun; 28(6):460-72. PMID: 21533567.
      View in: PubMed
    40. Baker WL, Colby JA, Tongbram V, Talati R, Silverman IE, White CM, Kluger J, Coleman CI. Neurothrombectomy devices for the treatment of acute ischemic stroke: state of the evidence. Ann Intern Med. 2011 Feb 15; 154(4):243-52. PMID: 21242342.
      View in: PubMed
    41. Trikudanathan G, Philip A, Dasanu CA, Baker WL. Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP. 2011 Jan; 12(1):26-31. PMID: 21206097.
      View in: PubMed
    42. Baker WL, Datta R. Pitavastatin: a new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor for the treatment of hyperlipidemia. Adv Ther. 2011 Jan; 28(1):13-27. PMID: 21170619.
      View in: PubMed
    43. Sood N, Reinhart KM, Baker WL. Combination therapy for the management of hypertension: A review of the evidence. Am J Health Syst Pharm. 2010 Jun 1; 67(11):885-94. PMID: 20484210.
      View in: PubMed
    44. Coleman CI, Tuttle LA, Teevan C, Baker WL, White CM, Reinhart KM. Antiplatelet agents for the prevention of arteriovenous fistula and graft thrombosis: a meta analysis. Int J Clin Pract. 2010 Aug; 64(9):1239-44. PMID: 20455955.
      View in: PubMed
    45. Phung OJ, Quercia RA, Keating K, Baker WL, Bell JL, White CM, Coleman CI. Improved glucose control associated with i.v. chromium administration in two patients receiving enteral nutrition. Am J Health Syst Pharm. 2010 Apr 1; 67(7):535-41. PMID: 20237381.
      View in: PubMed
    46. Courter JD, Baker WL, Nowak KS, Smogowicz LA, Desjardins LL, Coleman CI, Girotto JE. Increased clinical failures when treating acute otitis media with macrolides: a meta-analysis. Ann Pharmacother. 2010 Mar; 44(3):471-8. PMID: 20150506.
      View in: PubMed
    47. Colby JA, Silverman IE, Baker WL. Acute ischemic stroke: an update on endovascular treatment options. Conn Med. 2010 Feb; 74(2):97-101. PMID: 20218046.
      View in: PubMed
    48. Baker WL, Coleman CI, Lundbye JB. Clopidogrel and proton pump inhibitor use: what does the evidence really say? Conn Med. 2010 Jan; 74(1):27-31. PMID: 20175370.
      View in: PubMed
    49. Baker WL, Coleman CI, Kluger J, Reinhart KM, Talati R, Quercia R, Phung OJ, White CM. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease. Ann Intern Med. 2009 Dec 15; 151(12):861-71. PMID: 20008762.
      View in: PubMed
    50. Reinhart KM, White CM, Baker WL. Prasugrel: a critical comparison with clopidogrel. Pharmacotherapy. 2009 Dec; 29(12):1441-51. PMID: 19947804.
      View in: PubMed
    51. Baker WL, Tercius A, Anglade M, White CM, Coleman CI. A meta-analysis evaluating the impact of chitosan on serum lipids in hypercholesterolemic patients. Ann Nutr Metab. 2009; 55(4):368-74. PMID: 19923803.
      View in: PubMed
    52. Baker WL, Talati R, White CM, Coleman CI. Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2010 Jan; 87(1):98-107. PMID: 19913318.
      View in: PubMed
    53. Phung OJ, Baker WL, Matthews LJ, Lanosa M, Thorne A, Coleman CI. Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am J Clin Nutr. 2010 Jan; 91(1):73-81. PMID: 19906797.
      View in: PubMed
    54. Scholle JM, Baker WL, Talati R, Coleman CI. The effect of adding plant sterols or stanols to statin therapy in hypercholesterolemic patients: systematic review and meta-analysis. J Am Coll Nutr. 2009 Oct; 28(5):517-24. PMID: 20439548.
      View in: PubMed
    55. Baker WL, White CM, Cappelleri JC, Kluger J, Coleman CI. Understanding heterogeneity in meta-analysis: the role of meta-regression. Int J Clin Pract. 2009 Oct; 63(10):1426-34. PMID: 19769699.
      View in: PubMed
    56. Phung OJ, White CM, Baker WL, Coleman CI. Assessing the usefulness of health-related quality-of-life trials: a clinician's perspective using two COPD examples. Ann Pharmacother. 2009 Sep; 43(9):1496-505. PMID: 19690221.
      View in: PubMed
    57. Baker WL, Baker EL, Coleman CI. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Pharmacotherapy. 2009 Aug; 29(8):891-905. PMID: 19637942.
      View in: PubMed
    58. Baker WL, Cios DA, Sander SD, Coleman CI. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. J Manag Care Pharm. 2009 Apr; 15(3):244-52. PMID: 19326955.
      View in: PubMed
    59. Baker EL, Loewenthal T, Salerno E, Baker WL. Probable enoxaparin-induced hepatotoxicity. Am J Health Syst Pharm. 2009 Apr 1; 66(7):638-41. PMID: 19299370.
      View in: PubMed
    60. Talati R, Baker WL, Pabilonia MS, White CM, Coleman CI. The effects of barley-derived soluble fiber on serum lipids. Ann Fam Med. 2009 Mar-Apr; 7(2):157-63. PMID: 19273871; PMCID: PMC2653960.
    61. Baker WL, Baker EL, Coleman CI. The effect of plant sterols or stanols on lipid parameters in patients with type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract. 2009 May; 84(2):e33-7. PMID: 19243852.
      View in: PubMed
    62. Talati R, Baker WL, Patel AA, Reinhart K, Coleman CI. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Int J Clin Pract. 2009 Apr; 63(4):613-23. PMID: 19222614.
      View in: PubMed
    63. Talati R, Reinhart K, Baker W, White CM, Coleman CI. Pharmacologic treatment of advanced Parkinson's disease: a meta-analysis of COMT inhibitors and MAO-B inhibitors. Parkinsonism Relat Disord. 2009 Aug; 15(7):500-5. PMID: 19167259.
      View in: PubMed
    64. Baker WL, Anglade MW, Baker EL, White CM, Kluger J, Coleman CI. Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis. Eur J Cardiothorac Surg. 2009 Mar; 35(3):521-7. PMID: 19147369.
      View in: PubMed
    65. Baker WL, White CM. Role of prasugrel, a novel P2Y(12) receptor antagonist, in the management of acute coronary syndromes. Am J Cardiovasc Drugs. 2009; 9(4):213-29. PMID: 19655817.
      View in: PubMed
    66. Saranitzky E, White CM, Baker EL, Baker WL, Coleman CI. Feverfew for migraine prophylaxis: a systematic review. J Diet Suppl. 2009; 6(2):91-103. PMID: 22435410.
      View in: PubMed
    67. Sood N, Baker WL, Coleman CI. Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. Am J Clin Nutr. 2008 Oct; 88(4):1167-75. PMID: 18842808.
      View in: PubMed
    68. Baker WL, Silver D, White CM, Kluger J, Aberle J, Patel AA, Coleman CI. Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord. 2009 May; 15(4):287-94. PMID: 18774743.
      View in: PubMed
    69. Baker WL, White CM, Coleman CI. The role of soluble fiber in the management of patients with hypercholesterolemia: a review of the literature. Conn Med. 2008 Sep; 72(8):465-8. PMID: 18798380.
      View in: PubMed
    70. Sood N, Coleman CI, Kluger J, White CM, Padala A, Baker WL. The association among blood transfusions, white blood cell count, and the frequency of post-cardiothoracic surgery atrial fibrillation: a nested cohort study from the Atrial Fibrillation Suppression Trials I, II, and III. J Cardiothorac Vasc Anesth. 2009 Feb; 23(1):22-7. PMID: 18834823.
      View in: PubMed
    71. Baker WL, White CM, Coleman CI. Effect of nonergot dopamine agonists on symptoms of restless legs syndrome. Ann Fam Med. 2008 May-Jun; 6(3):253-62. PMID: 18474889; PMCID: PMC2384985.
    72. Coleman CI, Baker WL, Kluger J, White CM. Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials. J Hypertens. 2008 Apr; 26(4):622-9. PMID: 18327066.
      View in: PubMed
    73. Ruffin RT, Kluger J, Baker WL, Wills SM, White CM, Coleman CI. Association between perioperative NSAID use and post-cardiothoracic surgery atrial fibrillation, blood transfusions, and cardiovascular outcomes: a nested cohort study from the AF Suppression Trials (AFIST) I, II and III. Curr Med Res Opin. 2008 Apr; 24(4):1131-6. PMID: 18334081.
      View in: PubMed
    74. Baker WL, Gutierrez-Williams G, White CM, Kluger J, Coleman CI. Effect of cinnamon on glucose control and lipid parameters. Diabetes Care. 2008 Jan; 31(1):41-3. PMID: 17909085.
      View in: PubMed
    75. Kuti EL, Baker WL, White CM. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker. Curr Med Res Opin. 2007 Jun; 23(6):1239-44. PMID: 17559720.
      View in: PubMed
    76. Baker WL, Couch KA. Azithromycin for the secondary prevention of coronary artery disease: a meta-analysis. Am J Health Syst Pharm. 2007 Apr 15; 64(8):830-6. PMID: 17420199.
      View in: PubMed
    77. Baker WL, White CM. Renin-angiotensin system inhibitors for prevention of new-onset atrial fibrillation. Conn Med. 2007 Apr; 71(4):205-9. PMID: 17487005.
      View in: PubMed
    78. Baker WL, White CM. Post-cardiothoracic surgery atrial fibrillation: a review of preventive strategies. Ann Pharmacother. 2007 Apr; 41(4):587-98. PMID: 17374620.
      View in: PubMed
    79. Baker EL, Baker WL, Cloney DJ. Resolution of a phytobezoar with Aldoph's Meat Tenderizer. Pharmacotherapy. 2007 Feb; 27(2):299-302. PMID: 17253920.
      View in: PubMed
    80. Baker WL, White CM, Kluger J, Denowitz A, Konecny CP, Coleman CI. Effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay. Heart Rhythm. 2007 Apr; 4(4):461-8. PMID: 17399635.
      View in: PubMed
    81. Baker WL, Folstad J. Cardiovascular effects of migraine therapy. Prog Cardiovasc Nurs. 2003; 18(3):151-7,161. PMID: 12893978.
      View in: PubMed
    Baker's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _